Carroll Financial Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $1.71M | Buy |
7,606
+605
| +9% | +$128K | 0.09% | 133 |
|
|
2021
Q3 | $1.49M | Sell |
7,001
-402
| -5% | -$92.5K | 0.08% | 150 |
|
|
2021
Q2 | $1.8M | Buy |
7,403
+59
| +0.8% | +$14.5K | 0.1% | 126 |
|
|
2021
Q1 | $1.83M | Sell |
7,344
-174
| -2% | -$41.5K | 0.11% | 119 |
|
|
2020
Q4 | $1.73M | Sell |
7,518
-56
| -0.7% | -$12.9K | 0.12% | 113 |
|
|
2020
Q3 | $1.93M | Buy |
7,574
+41
| +0.5% | +$10.2K | 0.15% | 95 |
|
|
2020
Q2 | $1.78M | Buy |
7,533
+49
| +0.7% | +$11.2K | 0.15% | 93 |
|
|
2020
Q1 | $1.52M | Sell |
7,484
-16
| -0.2% | -$3.5K | 0.15% | 97 |
|
|
2019
Q4 | $1.81M | Sell |
7,500
-24
| -0.3% | -$5.29K | 0.14% | 93 |
|
|
2019
Q3 | $1.46M | Buy |
7,524
+88
| +1% | +$16.9K | 0.13% | 113 |
|
|
2019
Q2 | $1.37M | Buy |
7,436
+58
| +0.8% | +$10.4K | 0.12% | 110 |
|
|
2019
Q1 | $1.4M | Buy |
7,378
+201
| +3% | +$38.4K | 0.13% | 96 |
|
|
2018
Q4 | $1.42M | Buy |
7,177
+32
| +0.4% | +$6.24K | 0.16% | 87 |
|
|
2018
Q3 | $1.48M | Buy |
7,145
+24
| +0.3% | +$4.73K | 0.16% | 93 |
|
|
2018
Q2 | $1.31M | Buy |
7,121
+50
| +0.7% | +$8.84K | 0.14% | 100 |
|
|
2018
Q1 | $1.21M | Buy |
7,071
+339
| +5% | +$62.2K | 0.13% | 98 |
|
|
2017
Q4 | $1.17M | Sell |
6,732
-442
| -6% | -$78.2K | 0.13% | 101 |
|
|
2017
Q3 | $1.34M | Sell |
7,174
-904
| -11% | -$160K | 0.15% | 88 |
|
|
2017
Q2 | $1.39M | Buy |
8,078
+166
| +2% | +$27K | 0.17% | 84 |
|
|
2017
Q1 | $1.3M | Buy |
7,912
+2,465
| +45% | +$410K | 0.17% | 83 |
|
|
2016
Q4 | $796K | Buy |
5,447
+21
| +0.4% | +$3.16K | 0.11% | 105 |
|
|
2016
Q3 | $905K | Buy |
5,426
+53
| +1% | +$8.96K | 0.14% | 100 |
|
|
2016
Q2 | $817K | Buy |
5,373
+840
| +19% | +$131K | 0.14% | 103 |
|
|
2016
Q1 | $679K | Sell |
4,533
-7
| -0.2% | -$1.04K | 0.13% | 105 |
|
|
2015
Q4 | $736K | Sell |
4,540
-897
| -16% | -$141K | 0.15% | 99 |
|
|
2015
Q3 | $816K | Buy |
5,437
+145
| +3% | +$22.9K | 0.18% | 90 |
|
|
2015
Q2 | $812K | Buy |
5,292
+2,253
| +74% | +$361K | 0.18% | 87 |
|
|
2015
Q1 | $486K | Hold |
3,039
| – | – | 0.21% | 78 |
|
|
2014
Q4 | $460K | Sell |
3,039
-1,953
| -39% | -$304K | 0.29% | 62 |
|
|
2014
Q3 | $810K | Buy |
4,992
+975
| +24% | +$127K | 0.25% | 64 |
|
|
2014
Q2 | $475K | Buy |
4,017
+505
| +14% | +$58.5K | 0.13% | 103 |
|
|
2014
Q1 | $433K | Sell |
3,512
-395
| -10% | -$47.9K | 0.14% | 92 |
|
|
2013
Q4 | $445K | Buy |
3,907
+395
| +11% | +$44.9K | 0.16% | 92 |
|
|
2013
Q3 | $393K | Sell |
3,512
-261
| -7% | -$28.3K | 0.15% | 95 |
|
|
2013
Q2 | $372K | Buy |
+3,773
| New | +$392K | 0.18% | 89 |
|
Other funds holding AMGN
Carroll Financial Associates's AMGN Position: Q4 2021 in Review
Carroll Financial Associates increased its Amgen (AMGN) stake by 8.6% in Q4 2021, buying an estimated $128K and bringing the position to 7,606 shares worth $1.71M. The position accounts for 0.09% of the portfolio, ranked #133.
Carroll Financial Associates first reported a position in AMGN in Q2 2013 and has held it in 35 quarters since. The position peaked at $1.93M in Q3 2020. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.
- Carroll Financial Associates held 7,606 shares of Amgen worth $1.71M as of Q4 2021.
- Carroll Financial Associates bought 605 Amgen shares in Q4 2021, an estimated $128K.
- Amgen made up 0.09% of Carroll Financial Associates's portfolio in Q4 2021, its #133 holding.
- Carroll Financial Associates first reported a position in Amgen in Q2 2013 and has held it in 35 quarters since.
- Carroll Financial Associates's Amgen position peaked at $1.93M in Q3 2020.
- 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.